These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2140303)

  • 21. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
    Komers R; Cooper ME
    Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG; Ganten D; Lang RE; Unger T
    J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR; Jackson B
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
    Becker RH; Baldes L; Treudler M
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats.
    da Silva AS; Dias LD; Borges JF; Markoski MM; de Souza MS; Irigoyen MC; Machado UF; Schaan BD
    Life Sci; 2013 Jul; 92(24-26):1174-9. PubMed ID: 23680377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of ramipril on blood pressure, ACE-activity, sperm density and motility of spontaneously hypertensive rats during puberty.
    Hilse H; Siems WE; Heder G; Stahl F; Jentzsch KD
    Pharmazie; 1991 May; 46(5):360-1. PubMed ID: 1832776
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
    Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of natriuresis by sympathetic nerves and angiotensin II in conscious dogs.
    Persson PB; Ehmke H; Kögler U; Kirchheim H
    Am J Physiol; 1989 Mar; 256(3 Pt 2):F485-9. PubMed ID: 2522278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Tomita Y; Tsuchihashi T; Nakao Y; Iwase M; Sadoshima S; Fujishima M
    Jpn Circ J; 1990 Feb; 54(2):192-200. PubMed ID: 1972412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
    Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
    Vierhapper H; Witte PU; Waldhäusl W
    J Hypertens; 1986 Feb; 4(1):9-11. PubMed ID: 3007605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats.
    Brands MW; Bell TD; Fleming C; Labazi H; Sturgis LC
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):475-9. PubMed ID: 17439418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.
    Ding SS; Qiu C; Hess P; Xi JF; Zheng N; Clozel M
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):48-54. PubMed ID: 12827026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baroreflex setting and sensitivity in normal subjects: effects of pharmacologic inhibition of the angiotensin I converting enzyme.
    Düsing R; Kayser G; Wagner S; Scherf H; Glänzer K; Predel HG; Kramer HJ
    Am J Cardiol; 1987 Apr; 59(10):50D-54D. PubMed ID: 3034033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.